BHR Biosynex is a market leader in the provision of point of care diagnostics, with an established track record in women’s health, which has resulted in moving appropriate tests from the lab closer to the patient to better manage and treat people. This helps shorten patient pathways, improves the patient experience, and improves efficiency for consultants, nurses and other healthcare professionals involved in the care of women. With particular expertise in Pregnancy, Premature Rupture of Membranes, Pre-Term Labour, Group B Strep, and IVF, BHR Biosynex has a suite of rapid, point of care solutions for all healthcare settings.
Our point-of-care diagnostics have been carefully chosen to assist in streamlining healthcare delivery and improving patient outcomes. The products and services offered by BHR have proven to be extremely useful to healthcare teams, helping CCG Commissioners, STPs (Sustainability and Transformation Plans), GPs, and pharmacies to achieve service framework objectives in a meaningful, timely, and cost-effective manner. All our products are backed by extensive internal quality control (iQC) and External Quality Assurance (EQA) programmes.
We believe in giving customers the best possible support and after sales care, providing full access to our dedicated and experienced customer service and technical support teams.